Edition:
United Kingdom

Cleveland Biolabs Inc (CBLI.OQ)

CBLI.OQ on NASDAQ Stock Exchange Capital Market

3.43USD
16 Feb 2018
Change (% chg)

$-0.01 (-0.29%)
Prev Close
$3.44
Open
$3.45
Day's High
$3.45
Day's Low
$3.35
Volume
1,708
Avg. Vol
6,420
52-wk High
$5.55
52-wk Low
$1.41

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.30 -0.112
Jun '17 0.21 -0.500
Mar '17 0.57 -0.151
FY 2016 Dec '16 0.99 -0.112
Sep '16 1.14 0.104
Jun '16 0.58 -0.173
Mar '16 0.81 -0.061
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 83.93 32.90
P/E High - Last 5 Yrs. 9.46 292.71 45.97
P/E Low - Last 5 Yrs. 9.46 91.44 24.37
Beta -0.19 0.90 0.89
Price to Sales (TTM) 13.52 110.72 5.77
Price to Book (MRQ) 8.54 13.56 5.41
Price to Tangible Book (MRQ) 8.54 14.02 6.98
Price to Cash Flow (TTM) -- 71.33 23.42
% Owned Institutions 4.64 12.89 2.22

Dividends

  Company industry sector
Dividend Yield -- 0.31 1.50
Dividend Yield - 5 Year Avg -- 0.26 1.52
Dividend 5 Year Growth Rate -- 1.66 5.21
Payout Ratio(TTM) -- 15.70 43.72

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -64.15 398.33 9.24
Sales (TTM) vs TTM 1 Yr. Ago -7.80 78.63 5.59
Sales - 5 Yr. Growth Rate -16.73 32.11 10.27
EPS (MRQ) vs Qtr. 1 Yr. Ago -189.65 25.10 19.65
EPS (TTM) vs TTM 1 Yr. Ago 1.75 -- --
EPS - 5 Yr. Growth Rate -- 38.95 10.73
Capital Spending - 5 Yr. Growth Rate -59.84 40.24 15.19

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.80 2.18
Current Ratio (MRQ) 5.16 5.30 2.97
LT Debt to Equity (MRQ) 0.00 22.82 12.22
Total Debt to Equity (MRQ) 0.00 24.47 16.52
Interest Coverage (TTM) -- -98.78 33.13

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.03 54.70
Gross Margin - 5 Yr. Avg. -- 51.06 52.42
EBITD Margin (TTM) -195.94 -- --
EBITD - 5 Yr. Avg -377.16 -572.68 10.86
Operating Margin (TTM) -197.09 -717.10 4.64
Operating Margin - 5 Yr. Avg. -320.58 -594.00 6.26
Pre-Tax Margin (TTM) -253.47 -691.66 5.44
Pre-Tax Margin - 5 Yr. Avg. -264.44 -597.35 6.60
Net Profit Margin (TTM) -253.47 -692.88 1.76
Net Profit Margin - 5 Yr. Avg. -264.44 -600.21 2.91
Effective Tax Rate (TTM) -- 22.57 23.04
Effective Tax Rate - 5 Yr. Avg. -- 18.19 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) 194,134 22,602,121 855,667,832
Net Income/Employee (TTM) -492,081 2,968,747 100,655,557
Receivable Turnover (TTM) 4.40 20.14 5.78
Inventory Turnover (TTM) -- 2.36 3.35
Asset Turnover (TTM) 0.19 0.39 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -48.89 -1.05 10.98
Return on Assets - 5 Yr. Avg. -57.32 -0.57 12.37
Return on Investment (TTM) -119.26 1.66 14.43
Return on Investment - 5 Yr. Avg. -262.99 2.23 16.18
Return on Equity (TTM) -119.07 2.58 16.13
Return on Equity - 5 Yr. Avg. -367.36 3.13 17.47
  1 Year 3 Year 5 Year
Sales % 29.92 -25.44 -16.73
EPS (TTM) % 86.48 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Cleveland Biolabs Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 5.34%
# of Holders: 24
Total Shares Held: 602,736
3 Mo. Net Change: 151,486
# New Positions: 3
# Closed Positions: 3
# Increased Positions: 5
# Reduced Positions: 10
# Net Buyers: -5
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.